Latest AI and machine learning research in atherosclerosis for healthcare professionals.
Antihypertensive peptides (AHTPs) are short-chain peptides derived from food or bioproteins through ...
BACKGROUND AND AIMS: Conventional biomarkers such as low-density lipoprotein (LDL) and high-density ...
Atherosclerosis (AS) is a chronic inflammatory disease of the vascular wall driven by a complex inte...
BACKGROUND AND OBJECTIVE: Cerebral aneurysms affect 2-5% of the global population and pose a signifi...
Fibrosis is a maladaptive pathophysiological process characterized by excessive deposition of extrac...
Emerging organic pollutants (EOPs) are increasingly detected in wastewater and pose potential vascul...
Artificial intelligence (AI) is reshaping cardiovascular imaging, transforming it from a set of diag...
BACKGROUND AND AIMS: Pulmonary arterial hypertension (PAH) is a severe disease with limited effectiv...
Active arterial mechanics, governed by vascular smooth muscle contraction, are critical to physiolog...
OBJECTIVES: Automated artificial intelligence (AI)-based assessment of atherosclerosis burden applie...
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide despite major advances...
Time-of-flight (ToF) in PET improves image quality by enhancing the signal-to-noise ratio, and recen...
The lymphatic system-integral to fluid balance, immune surveillance, and lipid absorption-is frequen...
BACKGROUND: Postoperative acute ischemic stroke remains a critical complication of coronary artery b...
OBJECTIVE: Loss of oligodendrocytes (OLs) and myelin impairs neuronal firing and network stability, ...
BACKGROUND: This study compared changes in percentage atheroma volume (PAV) using an end-diastolic (...
Osteoporosis (OP) is a multifactorial disease, leading to abnormal bone remodeling, requiring target...